ASCO 2022 - DESTINY-Breast04 trial in HER2-low unresectable and/or metastatic breast cancer

Watch Now ASCO 2022 - DESTINY-Breast04 trial in HER2-low unresectable and/or metastatic breast cancer

AACR 2022: Recurrent NIB May Not Always Be Related to the Primary Lesion

Watch Now AACR 2022: Recurrent NIB May Not Always Be Related to the Primary Lesion

AACR 2022: AI Model Can Help Predict Adverse Events from New Drug Combinations

Watch Now AACR 2022: AI Model Can Help Predict Adverse Events from New Drug Combinations

AACR 2022: New CAR T-cell Therapy for Solid Tumors

Watch Now AACR 2022: New CAR T-cell Therapy for Solid Tumors

CLINICAL IMPACT SERIES: SABCS 2021 - Breast Cancer Review Expert Panel Discussion

Watch Now CLINICAL IMPACT SERIES: SABCS 2021 - Breast Cancer Review Expert Panel Discussion